Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPI 15715 for ICU Sedation
NCT00125398Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2005
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fospropofol disodium in agitation (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Safety and tolerability of infusions. Started Jul 2005; status: completed.
02
Drugs
fospropofol disodium
03
Conditions
agitation
Beyond the preview
Go deeper on NCT00125398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125398.